← Back to Search

Dietary Supplement

Active HDL supplement for High-Density Lipoprotein

N/A

Waitlist Available

Led By Mark Houston, MD

Research Sponsored by Metagenics, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baselineto end of study (week 12)

Awards & highlights

Study Summary

This trial will evaluate the effects of a supplement on various aspects of HDL (good cholesterol).

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baselineto end of study (week 12)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baselineto end of study (week 12)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baselineto end of study (week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

HDL mapping

HDL-FX test HDL-FX test

Secondary outcome measures

Dietary Intake

LP-PLA-2 test

Myloperoxidase (MPO)

Other outcome measures

Blood pressure (systolic/diastolic)

Body Mass Index

Waist Circumference

+1 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Active HDL supplementActive Control1 Intervention

25 subjects (ages 18-85 years old) will receive an active HDL supplement (CardioLux™HDL). They will take 2 capsules twice a day with food for 12 weeks. Total daily dosing is four (4) capsules.

Group II: PlaceboPlacebo Group1 Intervention

25 randomly selected subjects (ages 18-85 years old) will receive a matching Placebo. They will take 2 capsules twice each day with food for 12 weeks. Total daily dosing is four (4) capsules.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Metagenics, Inc.Lead Sponsor

14 Previous Clinical Trials

1,363 Total Patients Enrolled

Mark Houston, MDPrincipal InvestigatorHypertension Institute

2 Previous Clinical Trials

52 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are those over the age of 18 being accepted for this trial?

"According to the rules for enrollment, potential participants are required to be between 18 and 85 years old."

Answered by AI

Are participants still being accepted for this research endeavor?

"According to clinicaltrials.gov, this medical trial is not presently enrolling individuals. It was first announced on August 18th 2020 and the details were last updated on April 4th 2022. For those seeking participation in a similar study, there are 5 other trials actively recruiting right now."

Answered by AI

Am I eligible to take part in this research project?

"Those eligible to join this trial must have a set cholesterol level and their high-density lipoprotein score falls within the parameters. The recruitment process is estimated to take 53 patients between ages 18 and 85."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Oral Nutritional Supplement Effect on HDL Function

2020. "Oral Nutritional Supplement Effect on HDL Function". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04529174.